Market Overview:
The global smart insulin pens and pump market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of diabetes, technological advancements in smart insulin pens and pumps, and rising demand for homecare settings. Based on type, the global smart insulin pen and pump market is segmented into Smart Insulin Pens and Smart Insulin Pumps. The Smart Insulin Pen segment is further sub-segmented into disposable pens and reusable pens. The disposable pen segment is expected to grow at a higher CAGR during the forecast period as compared to the reusable pen segment due to their low cost and easy availability. Based on application, the global smart insulin pen and pump market is divided into hospitals & clinics, homecare settings, laboratories, research institutes & universities segments.
Product Definition:
A smart insulin pen is an insulin delivery device that monitors and records how much insulin is delivered. This information can be helpful for people with diabetes who need to closely monitor their blood sugar levels. A smart pump is a similar device that also calculates the amount of carbohydrates eaten and delivers appropriate doses of basal (background) insulin and bolus (mealtime) insulin based on the data entered. Both devices can provide alerts when blood sugar levels are too high or too low, helping people with diabetes to stay safe and healthy.
Smart Insulin Pens:
Insulin pens and pumps are the new trend in diabetes management. The smart insulin pen is a device that contains a chip, which allows it to communicate with the patient’s smartphone app, thereby enabling users to manage their blood glucose levels.
The major factor driving this market is increasing demand for advanced diabetes devices coupled with growing awareness about these devices among patients.
Smart Insulin Pump:
Smart Insulin Pens and Pump are connected to the internet. It can connect with the patient's smartphone or it can be directly connected to the insulin pump itself through a wireless connection. The smart insulin pumps market is expected to witness lucrative growth over forecast period owing to increasing demand for artificial pancreas and growing awareness about its usage among diabetic patients across the globe.
Application Insights:
The hospitals and clinics application segment dominated the global smart insulin pens and pump market in 2017. This can be attributed to a large number of diabetes treatment centers that have been established globally. These treatment centers provide subcutaneous insulin therapy, which is the most common method of delivering insulin for type 1 diabetes as well as other types of diabetes. The homecare segment is expected to witness lucrative growth over the forecast period due to increasing awareness about better management of type 2 diabetes among patients, coupled with rising availability of advanced products for homecare use.
The laboratories application segment accounted for a significant share in 2017 owing to an increase in demand from endocrinologists and physicians for testing purposes during diagnosis or evaluation stages of new drugs or devices intended for treating type 1 or other forms types 2 and 3 diabetes mellitus patients.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing cases of diabetes, rising adoption of smart devices for insulin delivery, and high healthcare expenditure in this region. In addition, presence of major players such as Medtronic; Novo Nordisk; and Dexcom GmbH is also contributing towards growth in this region.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as improving economic conditions leading to rise in disposable income resulting into increased penetration of advanced medical products including insulin pumps and pens for diabetes management along with growing awareness about these products among people affected with type 1 diabetes (T1D) & type 2 diabetes (T2D). Moreover, increase government initiatives are also expected favorably impact overall market development over the next eight years.
Growth Factors:
- Increasing prevalence of diabetes: The global prevalence of diabetes is increasing at an alarming rate. This is primarily due to the changing lifestyle and dietary habits of people across the world. As a result, there is an increased demand for insulin-based therapies such as smart insulin pens and pumps.
- Technological advancements: Smart insulin pens and pumps are becoming increasingly sophisticated with each passing day, thanks to the ongoing technological advancements. This has led to their wider adoption by patients as well as healthcare professionals alike.
- Growing awareness about diabetes: There is a growing awareness about diabetes among people all over the world, which has resulted in an increase in demand for smart insulin pens and pumps. This trend is likely to continue in the years to come, thereby propelling market growth further.
Scope Of The Report
Report Attributes
Report Details
Report Title
Smart Insulin Pens and Pump Market Research Report
By Type
Smart Insulin Pens, Smart Insulin Pump
By Application
Hospitals and Clinics, Homecare, Laboratories
By Companies
Companion Medical, Novo Nordisk, Emperra Gmbh E-Health technologies, Jiangasu Delfu medical device, Insulet Corporation, Cellenovo, Medronic, Roche, Ypsomed, Sooil Development
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Smart Insulin Pens and Pump Market Report Segments:
The global Smart Insulin Pens and Pump market is segmented on the basis of:
Types
Smart Insulin Pens, Smart Insulin Pump
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals and Clinics, Homecare, Laboratories
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Companion Medical
- Novo Nordisk
- Emperra Gmbh E-Health technologies
- Jiangasu Delfu medical device
- Insulet Corporation
- Cellenovo
- Medronic
- Roche
- Ypsomed
- Sooil Development
Highlights of The Smart Insulin Pens and Pump Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Smart Insulin Pens
- Smart Insulin Pump
- By Application:
- Hospitals and Clinics
- Homecare
- Laboratories
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Smart Insulin Pens and Pump Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A smart insulin pen and pump is a device that helps people with diabetes manage their blood sugar levels. The pens and pumps use sensors to detect when someone has taken their dose of insulin, and then release the correct amount of insulin into the person's bloodstream. This makes it easier for people with diabetes to take their medication correctly, and can help to prevent dangerous spikes in blood sugar levels.
Some of the major companies in the smart insulin pens and pump market are Companion Medical, Novo Nordisk, Emperra Gmbh E-Health technologies, Jiangasu Delfu medical device, Insulet Corporation, Cellenovo, Medronic, Roche, Ypsomed, Sooil Development.
The smart insulin pens and pump market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Smart Insulin Pens and Pump Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Smart Insulin Pens and Pump Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Smart Insulin Pens and Pump Market - Supply Chain
4.5. Global Smart Insulin Pens and Pump Market Forecast
4.5.1. Smart Insulin Pens and Pump Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Smart Insulin Pens and Pump Market Size (000 Units) and Y-o-Y Growth
4.5.3. Smart Insulin Pens and Pump Market Absolute $ Opportunity
5. Global Smart Insulin Pens and Pump Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Smart Insulin Pens and Pump Market Size and Volume Forecast by Type
5.3.1. Smart Insulin Pens
5.3.2. Smart Insulin Pump
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Smart Insulin Pens and Pump Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Smart Insulin Pens and Pump Market Size and Volume Forecast by Application
6.3.1. Hospitals and Clinics
6.3.2. Homecare
6.3.3. Laboratories
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Smart Insulin Pens and Pump Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Smart Insulin Pens and Pump Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Smart Insulin Pens and Pump Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Smart Insulin Pens and Pump Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Smart Insulin Pens and Pump Demand Share Forecast, 2019-2026
9. North America Smart Insulin Pens and Pump Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Smart Insulin Pens and Pump Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Smart Insulin Pens and Pump Market Size and Volume Forecast by Application
9.4.1. Hospitals and Clinics
9.4.2. Homecare
9.4.3. Laboratories
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Smart Insulin Pens and Pump Market Size and Volume Forecast by Type
9.7.1. Smart Insulin Pens
9.7.2. Smart Insulin Pump
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Smart Insulin Pens and Pump Demand Share Forecast, 2019-2026
10. Latin America Smart Insulin Pens and Pump Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Smart Insulin Pens and Pump Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Smart Insulin Pens and Pump Market Size and Volume Forecast by Application
10.4.1. Hospitals and Clinics
10.4.2. Homecare
10.4.3. Laboratories
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Smart Insulin Pens and Pump Market Size and Volume Forecast by Type
10.7.1. Smart Insulin Pens
10.7.2. Smart Insulin Pump
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Smart Insulin Pens and Pump Demand Share Forecast, 2019-2026
11. Europe Smart Insulin Pens and Pump Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Smart Insulin Pens and Pump Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Smart Insulin Pens and Pump Market Size and Volume Forecast by Application
11.4.1. Hospitals and Clinics
11.4.2. Homecare
11.4.3. Laboratories
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Smart Insulin Pens and Pump Market Size and Volume Forecast by Type
11.7.1. Smart Insulin Pens
11.7.2. Smart Insulin Pump
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Smart Insulin Pens and Pump Demand Share, 2019-2026
12. Asia Pacific Smart Insulin Pens and Pump Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Smart Insulin Pens and Pump Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Smart Insulin Pens and Pump Market Size and Volume Forecast by Application
12.4.1. Hospitals and Clinics
12.4.2. Homecare
12.4.3. Laboratories
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Smart Insulin Pens and Pump Market Size and Volume Forecast by Type
12.7.1. Smart Insulin Pens
12.7.2. Smart Insulin Pump
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Smart Insulin Pens and Pump Demand Share, 2019-2026
13. Middle East & Africa Smart Insulin Pens and Pump Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Smart Insulin Pens and Pump Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Smart Insulin Pens and Pump Market Size and Volume Forecast by Application
13.4.1. Hospitals and Clinics
13.4.2. Homecare
13.4.3. Laboratories
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Smart Insulin Pens and Pump Market Size and Volume Forecast by Type
13.7.1. Smart Insulin Pens
13.7.2. Smart Insulin Pump
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Smart Insulin Pens and Pump Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Smart Insulin Pens and Pump Market: Market Share Analysis
14.2. Smart Insulin Pens and Pump Distributors and Customers
14.3. Smart Insulin Pens and Pump Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Companion Medical
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Novo Nordisk
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Emperra Gmbh E-Health technologies
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Jiangasu Delfu medical device
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Insulet Corporation
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Cellenovo
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Medronic
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Roche
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Ypsomed
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Sooil Development
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
